Announcements around and during JPM Week each January often create waves throughout the biotechnology ecosystem. Join this webinar to learn what experienced dealmakers and market analysts found most relevant and influential from JPM Week to consider when planning your own capital formation and partnering priorities for 2024. Developments affecting M&A trends, the IPO window, licensing trends, and investor sentiment will all be discussed.
This webinar will also preview the program for the BIO CEO & Investor Conference, February 26-27, and explain how BIO’s One-on-One Partnering during the event can help you make progress against your 2024 priorities.
Donna LaVoie, President and CEO, LaVoieHealthScience
Sophie Jones, MD, Managing Director, Healthcare Investment Banking, J.P. Morgan
Evan Loh, MD, CEO, Paratek Pharmaceuticals
Kimberly Nearing, Venture Partner, BVCF
Tim Opler, PhD, Managing Director, Global Healthcare Group, Stifel